What is the difference between Ixifi and Remicade?
Medically reviewed by Drugs.com. Last updated on Sep 7, 2021.
Official Answer
by Drugs.comIxifi (infliximab-qbtx) is a tumor necrosis factor (TNF) blocker that is biosimilar to Remicade (infliximab).
Biosimilars are approved through an abbreviated licensure pathway for biological products that are shown to be interchangeable with an already FDA-approved biological product.
What Are Biosimilars? Top Facts You May Not Know
Ixifi and Remicade are used for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Ixifi is not interchangeable with Remicade at the pharmacy level unless specifically noted by the prescribing doctor.
For more information, see Comparing Ixifi vs Remicade
Related Medical Questions
- How does Tremfya work to treat plaque and psoriatic arthritis?
- How does Ilumya work to treat psoriasis?
- What are the new drugs for the treatment of rheumatoid arthritis (RA)?
- What causes Plaque Psoriasis?
- What are the new drugs for the treatment of plaque psoriasis?
- How many biosimilars have been approved in the United States?
- What is the difference between Inflectra and Remicade?
- What is the difference between Renflexis and Remicade?
Drug Information
Related Support Groups
- Psoriasis (76 questions, 283 members)
- Remicade (21 questions, 181 members)
- Infliximab (7 questions, 16 members)
- Ixifi (4 questions, 3 members)
- Rheumatoid Arthritis (270 questions, 1256 members)
- Ulcerative Colitis (44 questions, 176 members)
- Plaque Psoriasis (62 questions, 67 members)
- Psoriatic Arthritis (57 questions, 261 members)
- Crohn's Disease (33 questions, 270 members)
- Ankylosing Spondylitis (32 questions, 199 members)
- Inflammatory Bowel Disease (10 questions, 53 members)
- Toxic Epidermal Necrolysis (1 questions, 7 members)